首页 › 基金 › Twin Securities, Inc. › RNA

Twin Securities, Inc. 对 RNA 的持仓历史

ATRIUM THERAPEUTICS INC · 医疗保健

Twin Securities, Inc. 在 Q2 2026 的 13F 申报中披露持有 RNA(ATRIUM THERAPEUTICS INC)26,517 股,市值约 US$357K,约占其申报组合的 0.38%,在其申报持仓中市值排名第 10 位。 Twin Securities, Inc. 最近 2 个申报季度中有 2 个季度披露了 RNA 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q2 2026)26.52K 股
申报持仓市值$356.65K
组合权重0.38%
首次申报Q1 2026
最近变动减持
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Twin Securities, Inc. 对 RNA 的持仓演变

Twin Securities, Inc. 于 Q1 2026 首次披露 RNA 持仓:49,913 股(约 US$667K)。 在 2 次申报中,Twin Securities, Inc. 0 次增持、1 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 26,517 股、市值约 US$357K,环比减持 -23,396 股。。 持仓曾出现大幅变动:Q2 2026 减持约 47% (随后一个季度股价下跌 38%)。

逐季持仓明细

季度股数金额变化
Q1 2026 49.91K $667.34K 新进
Q2 2026 26.52K $356.65K 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 RNA 与 13F 数据

RNA(ATRIUM THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 116 只申报持有 RNA,申报仓位最大的包括:Sessa Capital IM, L.P. (US$20.2M), CRCM LP (US$8.6M), TIG Advisors, LLC (US$7.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 RNA 的基金

查看 RNA 的全部基金持有人 →

常见问题

How long has Twin Securities, Inc. held RNA?

Twin Securities, Inc. has disclosed RNA holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Twin Securities, Inc.'s current position in RNA?

As of Q2 2026, Twin Securities, Inc. holds 26.52K shares of RNA (ATRIUM THERAPEUTICS INC), valued at $356.65K, representing 0.38% of its reported portfolio and ranking #10.

Has Twin Securities, Inc. been buying or selling RNA?

In the latest 13F filing (Q2 2026), Twin Securities, Inc. reduced its position in RNA.

Which other funds hold RNA?

Other major institutional holders of RNA include Sessa Capital IM, L.P., CRCM LP, TIG Advisors, LLC, among 116 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.